# Investcorp Credit Management BDC, Inc.: financial statements, quarterly

ICMB · Nasdaq · CIK 1578348 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/icmb.md) · [Financials](/companies/icmb/financials.md) · [Filings](/companies/icmb/filings.md) · [Insiders](/companies/icmb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/icmb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [2,215](/filings/0000950170-23-062921.md) | [2,260](/filings/0000950170-24-016606.md) | [2,174](/filings/0000950170-24-059774.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [101](/filings/0000950170-24-125880.md) | [109](/filings/0000950170-24-016606.md) | [112](/filings/0000950170-24-059774.md) | [(54.7) d](/filings/0000950170-24-109384.md) | [222](/filings/0000950170-24-125880.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(1,684)](/filings/0000950170-24-125880.md) | [(2,868)](/filings/0000950170-24-016606.md) | [2,412](/filings/0000950170-25-070774.md) | [(1,952)](/filings/0000950170-25-107482.md) | [6,607](/filings/0001193125-25-277953.md) | [(565) d](/filings/0001193125-26-132860.md) | [2,206](/filings/0001193125-26-220107.md) | [(657)](/filings/0001193125-26-352658.md) | [(1,261)](/filings/0001193125-25-277953.md) | [(9,359) d](/filings/0001193125-26-132860.md) | [(8,629)](/filings/0001193125-26-220107.md) | [(1,110)](/filings/0001193125-26-352658.md) |
| Diluted EPS | $ per share | [(0.12)](/filings/0000950170-24-125880.md) | [(0.20)](/filings/0000950170-24-016606.md) | [0.17](/filings/0000950170-25-070774.md) | [(0.14)](/filings/0000950170-25-107482.md) | [0.46](/filings/0001193125-25-277953.md) | not reported | [0.15](/filings/0001193125-26-220107.md) | [(0.05)](/filings/0001193125-26-352658.md) | [(0.09)](/filings/0001193125-25-277953.md) | not reported | [(0.60)](/filings/0001193125-26-220107.md) | [(0.08)](/filings/0001193125-26-352658.md) |
| Basic EPS | $ per share | [(0.12)](/filings/0000950170-24-125880.md) | [(0.20)](/filings/0000950170-24-016606.md) | [0.17](/filings/0000950170-25-070774.md) | [(0.14)](/filings/0000950170-25-107482.md) | [0.46](/filings/0001193125-25-277953.md) | not reported | [0.15](/filings/0001193125-26-220107.md) | [(0.05)](/filings/0001193125-26-352658.md) | [(0.09)](/filings/0001193125-25-277953.md) | not reported | [(0.60)](/filings/0001193125-26-220107.md) | [(0.08)](/filings/0001193125-26-352658.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0000950170-23-062921.md) | [3.1](/filings/0000950170-24-016606.md) | [2.7](/filings/0000950170-25-070774.md) | [0.2](/filings/0001193125-26-132860.md) | [1.7](/filings/0001193125-25-277953.md) | [0.8](/filings/0001193125-26-132860.md) | [2.3](/filings/0001193125-26-220107.md) | [2.9](/filings/0001193125-26-352658.md) | [3.9](/filings/0001193125-25-277953.md) | [4.6](/filings/0001193125-26-352658.md) | [2.7](/filings/0001193125-26-220107.md) | [10.9](/filings/0001193125-26-352658.md) |
| Total assets | $m | [240](/filings/0000950170-23-062921.md) | [224](/filings/0000950170-24-016606.md) | [210](/filings/0000950170-24-059774.md) | [192](/filings/0001193125-26-132860.md) | [203](/filings/0000950170-24-125880.md) | [207](/filings/0001193125-26-132860.md) | [208](/filings/0000950170-25-070774.md) | [224](/filings/0000950170-25-107482.md) | [211](/filings/0001193125-25-277953.md) | [189](/filings/0001193125-26-352658.md) | [165](/filings/0001193125-26-220107.md) | [161](/filings/0001193125-26-352658.md) |
| Total liabilities | $m | [156](/filings/0000950170-23-062921.md) | [145](/filings/0000950170-24-016606.md) | [131](/filings/0000950170-24-059774.md) | [117](/filings/0001193125-26-132860.md) | [123](/filings/0000950170-24-125880.md) | [129](/filings/0001193125-26-132860.md) | [130](/filings/0000950170-25-070774.md) | [148](/filings/0000950170-25-107482.md) | [138](/filings/0001193125-25-277953.md) | [129](/filings/0001193125-26-352658.md) | [112](/filings/0001193125-26-220107.md) | [112](/filings/0001193125-26-352658.md) |
| Long-term debt | $m | [134](/filings/0000950170-24-125880.md) | [135](/filings/0000950170-24-016606.md) | [123](/filings/0000950170-25-070774.md) | [108](/filings/0001193125-26-132860.md) | [113](/filings/0001193125-25-277953.md) | [124](/filings/0001193125-26-132860.md) | [121](/filings/0001193125-26-220107.md) | [136](/filings/0001193125-26-352658.md) | [129](/filings/0001193125-25-277953.md) | [124](/filings/0001193125-26-132860.md) | [110](/filings/0001193125-26-220107.md) | [110](/filings/0001193125-26-352658.md) |
| Shareholders' equity | $m | [83.9](/filings/0000950170-23-062921.md) | [78.8](/filings/0000950170-24-016606.md) | [79.1](/filings/0000950170-24-059774.md) | [75.0](/filings/0001193125-26-132860.md) | [79.9](/filings/0000950170-24-125880.md) | [77.6](/filings/0001193125-26-132860.md) | [78.1](/filings/0000950170-25-070774.md) | [74.5](/filings/0001193125-26-352658.md) | [72.7](/filings/0001193125-25-277953.md) | [59.4](/filings/0001193125-26-352658.md) | [52.7](/filings/0001193125-26-220107.md) | [49.7](/filings/0001193125-26-352658.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [10.6](/filings/0000950170-24-125880.md) | [1.5 d](/filings/0000950170-24-016606.md) | [13.9](/filings/0000950170-25-070774.md) | [11.0 d](/filings/0001193125-26-132860.md) | [0.5](/filings/0000950170-24-125880.md) | [(7.2) d](/filings/0001193125-26-132860.md) | [5.1](/filings/0001193125-26-220107.md) | [(6.7) d](/filings/0001193125-26-352658.md) | [1.3 d](/filings/0001193125-25-277953.md) | [12.0 d](/filings/0001193125-26-132860.md) | [10.8](/filings/0001193125-26-220107.md) | [9.3 d](/filings/0001193125-26-352658.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.4](/filings/0000950170-24-016606.md) | [14.4](/filings/0000950170-24-059774.md) | [14.4](/filings/0000950170-24-125880.md) | [14.4](/filings/0000950170-24-016606.md) | [14.4](/filings/0000950170-25-070774.md) | [14.4](/filings/0000950170-25-107482.md) | [14.4](/filings/0001193125-25-277953.md) | [14.4](/filings/0001193125-26-220107.md) | [14.4](/filings/0001193125-26-352658.md) | [14.4](/filings/0001193125-25-277953.md) | [14.4](/filings/0001193125-26-220107.md) | [14.4](/filings/0001193125-26-352658.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 14,432,472 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001193125-26-352658.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.